However, the concordance rate of KRAS and BRAF mutation analysis was 94% and 100% in a previous report,10 suggesting only a marginal influence of whether the sample for mutation analysis is taken from the primary tumor or the metastasis. This evidence concerns the gene KRAS and neoplasm.